MiNK Therapeutics, Inc. Common Stock (INKT) is a publicly traded Healthcare sector company. As of November 6, 2026, INKT trades at $10.22 with a market cap of $54.09M and a P/E ratio of -4.78. INKT moved +0.00% today. Year to date, INKT is -18.02%; over the trailing twelve months it is -24.35%. Its 52-week range spans $6.34 to $76.00. Analyst consensus is buy with an average price target of $42.50. Rallies surfaces INKT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for INKT combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $10.22 |
| Market Cap | $54.09M |
| P/E Ratio | -4.78 |
| EPS | $-2.39 |
| Dividend Yield | 0.00% |
| 52-Week High | $76.00 |
| 52-Week Low | $6.34 |
| Volume | 1.86K |
| Avg Volume | 0 |
| Revenue (TTM) | $320.10K |
| Net Income | $-11.36M |
| Gross Margin | 0.00% |
2 analysts cover INKT: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $42.50.